Clinical trial
Biological Therapy and Radiation Therapy in Treating Patients With Newly…
NCT00052715 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00052715 |
|---|---|
| Title | Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | Phase II Trial Of Poly-ICLC For Glioblastoma |
| Acronym | Poly-ICLC |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | poly ICLC |
| Enrollment | 31 |
| Start date | Oct 23, 2002 |
| Primary completion | Feb 25, 2006 |
| Completion | Jan 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: